◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

XILIO THERAPEUTICS, INC.

CIK: 1840233 SIC: 2834
$31.80M
Revenue
$-58.49M
Net Income
-
Gross Margin
-137.64%
Op. Margin
$25.45M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 17 of 13 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
+ Total Revenue $19.07M $8.08M $2.93M $1.72M $2.26M $2.36M - - - - - - - - - - -
Revenue Growth % (YoY) 742.5% 243.0% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $21.00M $22.45M $16.78M $15.35M $17.02M $17.06M $17.49M $18.13M $17.36M $20.12M $23.53M $23.17M $20.21M $24.55M $21.22M $19.56M $15.96M
Research & Development $14.32M $15.33M $8.27M $8.84M $10.76M $11.22M $10.40M $11.74M $11.05M $13.22M $16.13M $15.00M $13.04M $16.25M $14.92M $11.35M $10.47M
+ Operating Income $-1.93M $-14.37M $-13.85M $-13.63M $-14.76M $-14.70M $-17.49M $-18.13M $-17.36M $-20.12M $-23.53M $-23.17M $-20.21M $-24.55M $-21.22M $-19.56M $-15.96M
Operating Margin % -10.1% -177.7% -472.7% -790.5% -652.3% -623.8% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Interest Expense - - - - $62.00K $62.00K $62.00K $99.00K $474.00K $332.00K $209.00K $175.00K $380.00K $240.00K $119.00K $121.00K $371.00K
Other Income/Expense $1.02M $-1.43M $586.00K $536.00K $742.00K $779.00K $284.00K $475.00K $613.00K $761.00K $880.00K $701.00K $416.00K $-61.00K $-129.00K $-145.00K $-290.00K
+ Net Income $-16.29M $-15.84M $-13.27M $-13.09M $-14.02M $-13.93M $-17.20M $-17.66M $-16.75M $-19.36M $-22.65M $-22.47M $-19.79M $-24.61M $-21.35M $-19.70M $-16.25M
Net Margin % -85.4% -196.0% -452.7% -759.5% -619.5% -590.8% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Basic EPS -0.11 -0.16 -0.18 -0.18 -0.22 -0.24 -0.62 -0.64 -0.61 -0.70 -0.83 -0.82 -0.72 -0.90 -0.78 62.66 -21.27
Diluted EPS -0.11 -0.16 -0.18 -0.18 -0.22 -0.24 -0.62 -0.64 -0.61 -0.70 -0.83 -0.82 -0.72 -0.90 -0.78 62.66 -21.27
Basic Shares Outstanding 144.1M 96.4M 74.7M 3.7M 63.5M 57.8M 27.9M 21K 27.5M 27.5M 27.4M 8K 27.4M 27.4M 27.4M 4.9M 764K
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Cash & Cash Equivalents $103.76M $121.55M $89.07M $55.29M $61.26M $74.95M $33.98M $44.70M $59.77M $75.38M $93.27M $120.39M $139.14M $159.41M $176.96M $198.05M $99.77M
Accounts Receivable - - - - - - $30.00M - - - - - - - - - -
Other Current Assets $2.83M $2.17M $4.13M $4.94M $2.05M $3.06M $5.21M $3.42M $4.71M $3.04M $3.71M $4.11M $3.17M $3.60M $4.13M $4.46M $3.40M
Total Current Assets $124.09M $123.72M $93.20M $60.23M $63.31M $78.01M $69.19M $48.13M $64.48M $78.42M $96.98M $124.50M $142.31M $163.01M $181.09M $202.52M $105.57M
Property Plant & Equipment $3.68M $4.02M $4.29M $4.47M $4.84M $5.14M $5.54M $5.94M $6.37M $6.80M $7.25M $7.25M $7.55M $7.44M $7.47M $7.62M $7.11M
Other Non-current Assets - - - - - $92.00K $121.00K $145.00K $169.00K $197.00K $232.00K $267.00K $301.00K $335.00K $359.00K $393.00K $427.00K
Total Assets $133.69M $133.81M $103.72M $71.08M $74.66M $89.87M $82.61M $60.93M $77.84M $92.36M $111.50M $139.16M $157.41M $178.13M $196.35M $218.06M $120.72M
Accounts Payable $2.30M $4.10M $2.27M $2.57M $972.00K $1.26M $746.00K $1.05M $1.49M $945.00K $2.01M $3.12M $1.81M $1.41M $2.32M $3.14M $3.82M
Accrued Liabilities $8.95M $5.62M $3.88M $9.98M $9.79M $9.74M $8.00M $10.50M $9.40M $7.14M $6.48M $10.33M $9.06M $12.09M $7.32M $8.75M $8.19M
Deferred Revenue $43.85M $42.28M $40.25M $13.52M $26.11M $26.52M $21.73M - - - - - - - - - -
Other Current Liabilities - - - - - $7.00K $28.00K $48.00K $68.00K $82.00K $82.00K $82.00K $82.00K $82.00K $82.00K $82.00K $82.00K
Total Current Liabilities $56.40M $53.26M $47.64M $27.26M $38.02M $38.64M $31.58M $15.96M $16.93M $16.29M $16.19M $21.12M $16.84M $17.77M $12.22M $12.78M $12.87M
Other Non-current Liabilities - - - - - - - - - $7.00K $26.00K $45.00K $64.00K $82.00K $100.00K $118.00K $1.52M
Total Liabilities $141.79M $126.74M $93.02M $53.48M $53.68M $56.46M $56.84M $24.10M $25.34M $24.98M $26.71M $33.52M $31.12M $33.91M $30.23M $32.63M $34.29M
Common Stock $5.00K $5.00K $5.00K $5.00K $4.00K $4.00K $3.00K $3.00K $3.00K $3.00K $3.00K $3.00K $3.00K $3.00K $3.00K $3.00K -
Retained Earnings $-429.15M $-412.86M $-397.02M $-383.75M $-370.66M $-356.64M $-342.71M $-325.51M $-307.86M $-291.11M $-271.75M $-249.11M $-226.64M $-206.85M $-182.24M $-160.89M $-141.19M
Total Stockholders Equity $-8.10M $7.07M $10.70M $17.60M $20.97M $33.42M $25.77M $36.83M $52.50M $67.38M $84.79M $105.65M $126.30M $144.22M $166.12M $185.43M $-136.46M
Total Liabilities & Equity $133.69M $133.81M $103.72M $71.08M $74.66M $89.87M $82.61M $60.93M $77.84M $92.36M $111.50M $139.16M $157.41M $178.13M $196.35M $218.06M $120.72M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Net Income $-16.29M $-15.84M $-13.27M $-13.09M $-14.02M $-13.93M $-17.20M $-17.66M $-58.75M $-19.36M $-22.65M $-22.47M $-19.79M $-24.61M $-21.35M $-19.70M $-16.25M
Depreciation & Amortization $1.22M $878.00K $497.00K $376.00K $1.27M $888.00K $443.00K $449.00K $1.45M $991.00K $499.00K $489.00K $1.36M $885.00K $440.00K $394.00K $1.10M
Stock-based Compensation $4.01M $2.89M $1.53M $1.52M $4.92M $3.34M $1.83M $1.93M $5.45M $3.59M $1.79M $1.81M $6.61M $4.74M $2.03M $2.07M $2.89M
Change in Receivables $17.50M - - - - - $30.00M - - - - - - - - - -
Change in Payables $-276.00K $1.52M $-590.00K $1.60M $-76.00K $205.00K $-304.00K $-438.00K $-1.62M $-2.17M $-1.36M $1.46M $-972.00K $-1.22M $-820.00K $-1.19M $-1.63M
Operating Cash Flow $-2.99M $14.50M $28.98M $-14.16M $-4.22M $9.45M $-10.50M $-13.43M $-55.19M $-41.82M $-25.25M $-18.22M $-57.50M $-37.59M $-20.84M $-17.16M $-63.59M
Capital Expenditure $423.00K $423.00K $22.00K $6.00K $30.00K $21.00K - - $486.00K $486.00K $170.00K $509.00K $1.36M $1.02M $254.00K $378.00K $722.00K
Investing Cash Flow $-423.00K $-423.00K $-22.00K $-6.00K $-30.00K $-21.00K - - $-486.00K $-486.00K $-170.00K $-509.00K $-1.36M $-1.02M $-254.00K $-378.00K $-722.00K
Debt Repayment - - - - $3.33M $3.33M $3.33M $1.67M $5.00M $2.78M $1.67M - - - - - $1.00M
Financing Cash Flow $51.91M $52.19M $4.83M $8.20M $20.99M $21.00M $954.00K $-1.63M $-4.92M $-2.68M $-1.69M $-21.00K $-48.00K $-26.00K $-5.00K $115.83M $144.84M
Net Change in Cash $48.49M $66.27M $33.79M $-5.96M $16.74M $30.43M $-9.55M $-15.06M $-60.59M $-44.99M $-27.11M $-18.75M $-58.91M $-38.64M $-21.09M $98.29M $80.53M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $19.07M $2.26M $30.08M $4.62M
Operating Expenses $21.00M $17.02M $60.23M $51.57M
Research & Development $14.32M $10.76M $37.92M $32.38M
Operating Income $-1.93M $-14.76M $-30.15M $-46.95M
Interest Expense - - - $62.00K
Other Income/Expense $1.02M $742.00K $180.00K $1.80M
Net Income $-16.29M $-14.02M $-45.40M $-45.15M
Basic EPS -0.11 -0.22 -0.43 -0.91
Diluted EPS -0.11 -0.22 -0.43 -0.91
Basic Shares Outstanding $144.11M $63.47M $105.34M $49.76M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $103.76M $55.29M
Other Current Assets $2.83M $4.94M
Total Current Assets $124.09M $60.23M
Property Plant & Equipment $3.68M $4.47M
Total Assets $133.69M $71.08M
Accounts Payable $2.30M $2.57M
Accrued Liabilities $8.95M $9.98M
Deferred Revenue $43.85M $13.52M
Total Current Liabilities $56.40M $27.26M
Total Liabilities $141.79M $53.48M
Common Stock $5.00K $5.00K
Retained Earnings $-429.15M $-383.75M
Total Stockholders Equity $-8.10M $17.60M
Total Liabilities & Equity $133.69M $71.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-16.29M $-14.02M $-45.40M $-45.15M
Depreciation & Amortization - - $1.22M $1.27M
Stock-based Compensation - - $4.01M $4.92M
Change in Receivables - - $17.50M -
Change in Payables - - $-276.00K $-76.00K
Operating Cash Flow - - $-2.99M $-4.22M
Capital Expenditure - - $423.00K $30.00K
Investing Cash Flow - - $-423.00K $-30.00K
Debt Repayment - - - $3.33M
Financing Cash Flow - - $51.91M $20.99M
Net Change in Cash - - $48.49M $16.74M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...